PD-1, mainly expressed in activated T cells, B cells and macrophages, binds to ligands (PD-L1 and PD-L2) to inhibit T cell activity, induce apoptosis of tumor-specific T cells and suppress Tregs apoptosis (234). The gene discussed is RPL17; the disease is neoplasm.